Abundance Wealth Counselors Gilead Sciences, Inc. Transaction History

Abundance Wealth Counselors

$217 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$71.58 - $87.29 $77,592 - $94,622	1,084 Added 4.24%	26,673 $1.95 Million
Q4 2023 Jan 17, 2024	BUY	$73.27 - $83.09 $36,048 - $40,880	492 Added 1.96%	25,589 $2.07 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $1.86 Million - $2.02 Million	25,097 New	25,097 $1.88 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $138,307 - $157,575	-1,789 Reduced 6.43%	26,018 $2.16 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $13,398 - $19,236	215 Added 0.78%	27,807 $2.39 Million
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $37,748 - $43,118	634 Added 2.35%	27,592 $1.7 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $70,707 - $79,637	1,225 Added 4.76%	26,958 $1.67 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $49,289 - $61,765	851 Added 3.42%	25,733 $1.53 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $1.61 Million - $1.83 Million	24,882 New	24,882 $1.81 Million
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $1.58 Million - $1.71 Million	-23,386 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $101 Million - $110 Million	-1,586,974 Reduced 98.55%	23,386 $1.61 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $101 Million - $111 Million	1,595,691 Added 10877.98%	1,610,360 $23,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $863,520 - $985,276	14,392 Added 5195.67%	14,669 $948,000
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $626,820 - $715,201	-10,447 Reduced 97.42%	277 $18,000
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $59,709 - $68,035	1,054 Added 10.9%	10,724 $625,000
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $246,226 - $309,587	3,965 Added 69.5%	9,670 $611,000
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $412,699 - $479,220	5,705 New	5,705 $439,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.64 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.38 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.05 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.96 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.

Account